ArticleEvidence-based complementary and alternative medicine : eCAM2023

Retracted: Low-Dose Apatinib Improves the Prognosis of Patients with Recurrent High-Grade Gliomas.

Evidence-Based Complementary And Alternative MedicinePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.